GlassScriptPhysician profile
Chad Anthony Amato
NPI 1164916318
$11,444.39
in general payments reported to CMS, 2019-2025
16 companies · $2,605 in 2025
The $2,605 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $160 · 2021: $1,650 · 2022: $2,191 · 2023: $2,910 · 2024: $1,705 · 2025: $2,605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,880 · Food and Beverage: $2,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,880.46 |
| Food and Beverage | $2,339.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,663.10 | 2024-2025 | |
| Axogen | $2,076.37 | 2022-2023 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Pinnacle, INC | $1,414.80 | 2024-2025 | |
| Novus Surgical Solutions LLC | $1,291.43 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $1,180.52 | 2021-2022 | |
| Stryker Corporation | $750.93 | 2022-2023 | Infinity, Aequalis Perform, Simpliciti |
| Skeletal Dynamics INC | $610.33 | 2023 | Geminus, Ijs, Align |
| Acumed LLC | $415.32 | 2021-2022 | |
| Depuy Synthes Sales INC. | $349.23 | 2019-2025 | Na, Tfn-Advance, Motoband |
| Integra Lifesciences Corporation | $186.66 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cerapedics INC. | $151.45 | 2022 | |
| Medical Device Business Services, INC. | $110.00 | 2023 | Sigma |
| Novus Surgical Consultants | $97.61 | 2022-2023 | |
| Globus Medical, INC. | $67.31 | 2021 | |
| Endo USA, INC. | $56.81 | 2025 | Xiaflex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22.52 | 2024 | Ascension |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Amato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.